SINGAPORE, July 7, 2025 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China National Medical Products Administration (NMPA) has cleared the...
Hence then, the article about scg cell therapy announces clearance of investigational new drug application by the china nmpa for scg101v was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V )
Also on site :
- Skanska signs additional contract with existing client to build a data center in USA for USD 228M, about SEK 2.2 billion
- NW Indiana police investigating after person found dead in field
- ‘No way out’: Telangana student dies in Germany after jumping from burning apartment on New Year’s Eve